DRUG Bright Minds Biosciences Inc. Common Stock Pharmaceutical Preparations Best Pharmaceutical Stocks 2026 →

Bright Minds Biosciences (DRUG) Stock: Buy, Sell, or Hold?

$23.57
+0.96 (+4.25%) ▲
5d: +24.31% 30d: -54.11% 90d: -69.78%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (90%)
Quality Score
49/100
Position
OVERSOLD
30-Day Fair Range
$30.34 – $57.88
Position: OVERSOLD
Forward P/E & Valuation
-3.0x
Next 12M consensus est.
Wall Street Target
$117.11
+417.9% upside
Options IV & Volume
3th pct IV
HIGH volume confirmation
Support / Resistance
$17.40 / $57.79
Trend: Strong Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: DRUG shows conflicting indicators. Wait for confirmation before entering.

Get Alerted When DRUG Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: DRUG is currently trading at $23.57, which is considered oversold relative to its 30-day fair value range of $30.34 to $57.88.

Technical Outlook: Technically, DRUG is in a strong downtrend. Immediate support is located at $17.40, while resistance sits at $57.79. The stock is showing strong short-term momentum, up 4.2% recently.

Market Sentiment: The stock scores a mixed 55/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (3th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $117.11 (+417.9%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $30.34 - $57.88
Company Quality Score 49/100 (HOLD)
Options IV Signal 3th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 90.4%

Trading Range & Key Levels

30-Day Trading Range $30.34 - $57.88
Current vs Trading Range OVERSOLD
Expected Move (7 Days) ±$3.13 (13.3%)
Support Level $17.40
Resistance Level $57.79
Current Trend Strong Downtrend
Technical data as of Nov 11, 2026

Quantitative Signal Breakdown

  • BULLISH: Price oversold vs 30-day range
  • BULLISH: Options cheap (IV 3th percentile)
  • NEUTRAL: Mixed technical signals (55/100)
  • BULLISH: High volume confirmation
  • BULLISH: Strong upward momentum (+4.2%)
  • BULLISH: Trading 417.9% below Wall St target ($117.11)
  • WARNING: Composite score 49/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -2.96
Wall Street Target $117.11 (+417.9%)
Share DRUG Analysis

Share this live DRUG analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (DRUG)

Bullish 3 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary: Traders on StockTwits express bullish sentiment towards $DRUG, reminiscing about its past price performance and drawing parallels to other successful stocks.
Key Retail Themes: Price Performance Comparison Success Stories
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 3:09 PM ET
Data refreshes hourly during market hours. Next update: 4:09 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for DRUG.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 35 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 62 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 43 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive DRUG Research Pages
DRUG Technical Chart DRUG Price Prediction DRUG Intrinsic Value DCF DRUG Earnings Date Why is DRUG Moving Today? DRUG Investment Advisor DRUG Fair Price Analyzer DRUG Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals